Drugs / Meningococcal (Groups A,C,Y and W-135-DT) Polysaccharide Conjugate Vaccine
Meningococcal (Groups A,C,Y and W-135-DT) Polysaccharide Conjugate Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01482052 Comparator | Nov 2011 → Jan 2013 | meningococcal meningitis | JN-International Medical Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal (Groups A,C,Y and W-135-DT) Polysaccharide Conjugate Vaccine | “Meningococcal (Groups A,C,Y and W-135-DT) Polysaccharide Conjugate Vaccine 0.5 mL dose, intramuscular.” NCT01482052 ↗ |
| Route | Intramuscular | “0.5 mL dose, intramuscular” NCT01482052 ↗ |